Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ShengXian-QuYu Decoction in Heart Failure
NCT05583773Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Mar 2023
- Primary completion
- Aug 2025
- Modality
- TCM (Traditional Chinese Medicine), HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of Shengxian-Quyu Decoction in heart failure with reduced ejection fraction (HFrEF), heart failure with mildly reduced ejection fraction (HFmrEF), sponsored by China-Japan Friendship Hospital. Started Mar 2023; status: recruiting.
02
Drugs
Shengxian-Quyu Decoction
03
Conditions
heart failure with reduced ejection fraction (HFrEF)heart failure with mildly reduced ejection fraction (HFmrEF)
Beyond the preview
Go deeper on NCT05583773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05583773.